[Form 4] SELECT MEDICAL HOLDINGS CORP Insider Trading Activity
Insider activity: Director Thomas Daniel filed Form 4 for Select Medical Holdings (SEM) disclosing a grant of 14,035 restricted shares on 07/29/2025 (transaction code 鈥淎鈥�). The award carries a $0 purchase price and vests in full on 07/29/2026. Following the grant, Daniel directly owns 80,035 common shares; no derivative securities or sales were reported.
The filing represents routine director compensation and modestly increases insider ownership. No cash outlay, option exercises or open-market purchases occurred, so the transaction is unlikely to materially affect near-term supply-demand dynamics for SEM shares.
Attivit脿 degli insider: Il direttore Thomas Daniel ha presentato il Modulo 4 per Select Medical Holdings (SEM) dichiarando una concessione di 14.035 azioni vincolate il 29/07/2025 (codice transazione 鈥淎鈥�). Il premio ha un prezzo di acquisto pari a $0 e matura completamente il 29/07/2026. Dopo la concessione, Daniel possiede direttamente 80.035 azioni ordinarie; non sono stati segnalati titoli derivati n茅 vendite.
La comunicazione rappresenta una normale remunerazione per il direttore e aumenta modestamente la partecipazione degli insider. Non essendoci stati esborsi in contanti, esercizi di opzioni o acquisti sul mercato aperto, la transazione difficilmente influenzer脿 in modo significativo la dinamica domanda-offerta a breve termine delle azioni SEM.
Actividad de insiders: El director Thomas Daniel present贸 el Formulario 4 para Select Medical Holdings (SEM) revelando una concesi贸n de 14,035 acciones restringidas el 29/07/2025 (c贸digo de transacci贸n 鈥淎鈥�). La adjudicaci贸n tiene un precio de compra de $0 y se consolida completamente el 29/07/2026. Tras la concesi贸n, Daniel posee directamente 80,035 acciones ordinarias; no se reportaron valores derivados ni ventas.
La presentaci贸n representa una compensaci贸n rutinaria para el director y aumenta modestamente la propiedad de los insiders. No hubo desembolsos en efectivo, ejercicios de opciones ni compras en el mercado abierto, por lo que la transacci贸n probablemente no afectar谩 materialmente la din谩mica de oferta y demanda a corto plazo de las acciones de SEM.
雮措秬鞛� 瓯半灅 雮挫棴: 鞚挫偓 韱犽鞀� 雼る媹鞐橃潃 Select Medical Holdings(SEM)鞐� 雽�頃� 2025雲� 7鞗� 29鞚检棎 14,035欤检潣 鞝滍暅 欤检嫕 攵�鞐�毳� 鞁犼碃頃橂姅 Form 4毳� 鞝滌稖頄堨姷雼堧嫟(瓯半灅 旖旊摐 鈥淎鈥�). 鞚� 氤挫儊鞚� 甑Г 臧�瓴╈澊 $0鞚措┌ 2026雲� 7鞗� 29鞚检棎 鞝勳暋 旆摑霅╇媹雼�. 攵�鞐� 頉� 雼る媹鞐橃潃 歆侅爲 80,035欤检潣 氤错喌欤�毳� 氤挫湢頃橁碃 鞛堨溂氅�, 韺岇儩 歃濌秾鞚措倶 毵る弰 雮挫棴鞚� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�.
鞚措矆 鞁犼碃電� 鞚挫偓鞚� 鞝曣赴 氤挫儊鞐� 頃措嫻頃橂┌ 雮措秬鞛� 歆�攵勳潉 靻岉彮 歃濌皜鞁滍偟雼堧嫟. 順勱笀 歆�於�, 鞓奠厴 頄夓偓 霕愲姅 瓿店皽 鞁滌灔 毵れ垬電� 鞐嗢棃鞙茧瘈搿� 鞚措矆 瓯半灅臧� 雼赴鞝侅溂搿� SEM 欤检嫕鞚� 靾橁笁鞐� 韥� 鞓來枼鞚� 氙胳範 臧�電レ劚鞚� 雮姷雼堧嫟.
Activit茅 des initi茅s : Le directeur Thomas Daniel a d茅pos茅 le formulaire 4 pour Select Medical Holdings (SEM), r茅v茅lant une attribution de 14 035 actions restreintes le 29/07/2025 (code de transaction 芦 A 禄). Cette attribution est 脿 prix d鈥檃chat nul et devient enti猫rement acquise le 29/07/2026. Apr猫s cette attribution, Daniel d茅tient directement 80 035 actions ordinaires ; aucun titre d茅riv茅 ni vente n鈥檃 茅t茅 signal茅.
Cette d茅claration correspond 脿 une r茅mun茅ration habituelle du directeur et augmente modestement la d茅tention d鈥檌niti茅s. Aucun d茅caissement en esp猫ces, exercice d鈥檕ptions ou achat sur le march茅 ouvert n鈥檃 eu lieu, si bien que cette transaction est peu susceptible d鈥檃ffecter significativement l鈥櫭﹒uilibre offre-demande 脿 court terme des actions SEM.
滨苍蝉颈诲别谤-础办迟颈惫颈迟盲迟别苍: Direktor Thomas Daniel reichte am 29.07.2025 ein Formular 4 f眉r Select Medical Holdings (SEM) ein, in dem er eine Gew盲hrung von 14.035 eingeschr盲nkten Aktien (Transaktionscode 鈥濧鈥�) offenlegte. Die Zuteilung hat einen Kaufpreis von 0 $ und f盲llt vollst盲ndig am 29.07.2026 frei. Nach der Gew盲hrung besitzt Daniel direkt 80.035 Stammaktien; Derivate oder Verk盲ufe wurden nicht gemeldet.
Die Meldung stellt eine routinem盲脽ige Verg眉tung des Direktors dar und erh枚ht den Insider-Besitz geringf眉gig. Da keine Barauslagen, Optionsaus眉bungen oder K盲ufe am offenen Markt stattfanden, wird die Transaktion die kurzfristigen Angebots-Nachfrage-Dynamiken der SEM-Aktien voraussichtlich nicht wesentlich beeinflussen.
- Increased insider ownership: Director鈥檚 stake rises by 14,035 shares, strengthening alignment with shareholders.
- No open-market purchase: Shares were granted at $0, so the filing lacks the bullish signal of a cash-backed buy.
- Minor dilution: Issuance of new shares, though immaterial relative to total outstanding, is incrementally dilutive.
Insights
TL;DR: Routine restricted-stock grant; immaterial dilution but slightly better alignment of director and shareholder interests.
The Form 4 shows a typical board compensation grant rather than an open-market buy, so signalling value is limited. The additional 14,035 shares lift Daniel鈥檚 direct stake to 80,035, a ~21% increase in his holdings but negligible versus SEM鈥檚 ~128 million shares outstanding. Because the shares were issued at no cost and vest over one year, they contribute minor dilution yet improve incentive alignment in 2026. Overall impact on valuation, liquidity and governance is neutral.
Attivit脿 degli insider: Il direttore Thomas Daniel ha presentato il Modulo 4 per Select Medical Holdings (SEM) dichiarando una concessione di 14.035 azioni vincolate il 29/07/2025 (codice transazione 鈥淎鈥�). Il premio ha un prezzo di acquisto pari a $0 e matura completamente il 29/07/2026. Dopo la concessione, Daniel possiede direttamente 80.035 azioni ordinarie; non sono stati segnalati titoli derivati n茅 vendite.
La comunicazione rappresenta una normale remunerazione per il direttore e aumenta modestamente la partecipazione degli insider. Non essendoci stati esborsi in contanti, esercizi di opzioni o acquisti sul mercato aperto, la transazione difficilmente influenzer脿 in modo significativo la dinamica domanda-offerta a breve termine delle azioni SEM.
Actividad de insiders: El director Thomas Daniel present贸 el Formulario 4 para Select Medical Holdings (SEM) revelando una concesi贸n de 14,035 acciones restringidas el 29/07/2025 (c贸digo de transacci贸n 鈥淎鈥�). La adjudicaci贸n tiene un precio de compra de $0 y se consolida completamente el 29/07/2026. Tras la concesi贸n, Daniel posee directamente 80,035 acciones ordinarias; no se reportaron valores derivados ni ventas.
La presentaci贸n representa una compensaci贸n rutinaria para el director y aumenta modestamente la propiedad de los insiders. No hubo desembolsos en efectivo, ejercicios de opciones ni compras en el mercado abierto, por lo que la transacci贸n probablemente no afectar谩 materialmente la din谩mica de oferta y demanda a corto plazo de las acciones de SEM.
雮措秬鞛� 瓯半灅 雮挫棴: 鞚挫偓 韱犽鞀� 雼る媹鞐橃潃 Select Medical Holdings(SEM)鞐� 雽�頃� 2025雲� 7鞗� 29鞚检棎 14,035欤检潣 鞝滍暅 欤检嫕 攵�鞐�毳� 鞁犼碃頃橂姅 Form 4毳� 鞝滌稖頄堨姷雼堧嫟(瓯半灅 旖旊摐 鈥淎鈥�). 鞚� 氤挫儊鞚� 甑Г 臧�瓴╈澊 $0鞚措┌ 2026雲� 7鞗� 29鞚检棎 鞝勳暋 旆摑霅╇媹雼�. 攵�鞐� 頉� 雼る媹鞐橃潃 歆侅爲 80,035欤检潣 氤错喌欤�毳� 氤挫湢頃橁碃 鞛堨溂氅�, 韺岇儩 歃濌秾鞚措倶 毵る弰 雮挫棴鞚� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�.
鞚措矆 鞁犼碃電� 鞚挫偓鞚� 鞝曣赴 氤挫儊鞐� 頃措嫻頃橂┌ 雮措秬鞛� 歆�攵勳潉 靻岉彮 歃濌皜鞁滍偟雼堧嫟. 順勱笀 歆�於�, 鞓奠厴 頄夓偓 霕愲姅 瓿店皽 鞁滌灔 毵れ垬電� 鞐嗢棃鞙茧瘈搿� 鞚措矆 瓯半灅臧� 雼赴鞝侅溂搿� SEM 欤检嫕鞚� 靾橁笁鞐� 韥� 鞓來枼鞚� 氙胳範 臧�電レ劚鞚� 雮姷雼堧嫟.
Activit茅 des initi茅s : Le directeur Thomas Daniel a d茅pos茅 le formulaire 4 pour Select Medical Holdings (SEM), r茅v茅lant une attribution de 14 035 actions restreintes le 29/07/2025 (code de transaction 芦 A 禄). Cette attribution est 脿 prix d鈥檃chat nul et devient enti猫rement acquise le 29/07/2026. Apr猫s cette attribution, Daniel d茅tient directement 80 035 actions ordinaires ; aucun titre d茅riv茅 ni vente n鈥檃 茅t茅 signal茅.
Cette d茅claration correspond 脿 une r茅mun茅ration habituelle du directeur et augmente modestement la d茅tention d鈥檌niti茅s. Aucun d茅caissement en esp猫ces, exercice d鈥檕ptions ou achat sur le march茅 ouvert n鈥檃 eu lieu, si bien que cette transaction est peu susceptible d鈥檃ffecter significativement l鈥櫭﹒uilibre offre-demande 脿 court terme des actions SEM.
滨苍蝉颈诲别谤-础办迟颈惫颈迟盲迟别苍: Direktor Thomas Daniel reichte am 29.07.2025 ein Formular 4 f眉r Select Medical Holdings (SEM) ein, in dem er eine Gew盲hrung von 14.035 eingeschr盲nkten Aktien (Transaktionscode 鈥濧鈥�) offenlegte. Die Zuteilung hat einen Kaufpreis von 0 $ und f盲llt vollst盲ndig am 29.07.2026 frei. Nach der Gew盲hrung besitzt Daniel direkt 80.035 Stammaktien; Derivate oder Verk盲ufe wurden nicht gemeldet.
Die Meldung stellt eine routinem盲脽ige Verg眉tung des Direktors dar und erh枚ht den Insider-Besitz geringf眉gig. Da keine Barauslagen, Optionsaus眉bungen oder K盲ufe am offenen Markt stattfanden, wird die Transaktion die kurzfristigen Angebots-Nachfrage-Dynamiken der SEM-Aktien voraussichtlich nicht wesentlich beeinflussen.
FAQ
What insider transaction did SEM report on 07/29/2025?
At what price were the shares acquired?
When will the granted shares vest?
How many SEM shares does the director now own?
Did the filing include any stock sales or option exercises?
